Skip to Main Content

Paper Details

Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.
Clin Cancer Res
84
2017
-, CAR, Chimeric Antigen Receptor, Dual-specific Chimeric Antigen Receptor T Cells, Her2, Her2+, Her2+ tumors, IFN, IL2, Mice, Solid Tumors, T cells, TCR, Vaccinia virus, cancers, chemokine receptor CXCR3, chimeric antigen receptor, dual-specific T cells, gp100, leukemias, liver tumors, melanocyte protein, mice, mouse, neurologic, self, solid cancers, solid tumors, tumor, tumors, vital tissues
Author NameAffiliation
Ricky W JohnstonePeter MacCallum Cancer Center
Ricky W JohnstoneUniversity of Melbourne
Zhiya YuCenter for Cancer Research, National Cancer Institute, National Institute of Health
Zhiya YuCenter for Cancer Research, National Cancer Institute, National Institute of Health
Steven A RosenbergCenter for Cancer Research, National Cancer Institute, National Institute of Health
Steven A RosenbergCenter for Cancer Research, National Cancer Institute, National Institute of Health
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute, National Institute of Health
Nicholas P RestifoCenter for Cancer Research, National Cancer Institute, National Institute of Health
  • 1 - 8

Datasets

Release 1.2